Role of nuclear imaging in cardiac resynchronization therapy

Expert Review of Cardiovascular Therapy

Volumn 7, Issue 1, 2009, Pages 65-72

  Boogers, Mark M ^a   Chen, Ji ^b   Bax, Jereon J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac resynchronization therapy; Gated myocardial perfusion single photon emission computed tomography; Left ventricular dyssynchrony

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; FLUORODEOXYGLUCOSE F 18;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; GATED MYOCARDIAL PERFUSION SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; GLUCOSE UTILIZATION; HEART FAILURE; HEART INNERVATION; HEART LEFT VENTRICLE DYSSYNCHRONY; HEART LEFT VENTRICLE DYSSYNNERGY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE LEAD POSITION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE SYSTOLIC PRESSURE; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART VENTRICLE PACING; HEMODYNAMICS; HISTOGRAM; HUMAN; ISCHEMIC CARDIOMYOPATHY; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; QRS COMPLEX; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TISSUE DOPPLER IMAGING; ELECTROCARDIOGRAPHY; HEART PACING; METHODOLOGY; PATHOPHYSIOLOGY; SCAR; SCINTISCANNING; TREATMENT OUTCOME;

CARDIAC PACING, ARTIFICIAL; CICATRIX; CLINICAL TRIALS AS TOPIC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART FAILURE; HUMANS; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 60549084716     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.7.1.65     Document Type: Review

References (61)

1. Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117(4), 25-146 (2008).
2. Lozano I, Bocchiardo M, Achtelik M et al. Impact of biventricular pacing on mortality in a randomized crossover study of patients with heart failure and ventricular arrhythmias. Pacing Clin. Electrophysiol. 23(11), 1711-1712 (2000).
3. Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med. 344(12), 873-880 (2001).
4. Auricchio A, Stellbrink C, Sack S et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J. Am. Coll. Cardiol. 39(12), 2026-2033 (2002).
5. Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med. 346(24), 1845-1853 (2002).
6. Auricchio A, Stellbrink C, Butter C et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J. Am. Coll. Cardiol. 42(12), 2109-2116 (2003).
7. Young JB, Abraham WT, Smith AL et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289(20), 2685-2694 (2003).
8. Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 352(15), 1539-1549 (2005).
9. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350(21), 2140-2150 (2004).
10. Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/ AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117(21), 350-408 (2008).
11. Swedberg K, Cleland J, Dargie H et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur. Heart J. 26(11), 1115-1140 (2005).
12. Bax JJ, Van der Wall EE, Schalij MJ. Cardiac resynchronization therapy for heart failure. N. Engl. J. Med. 347(22), 1803-1804 (2002).
13. Bax JJ, Abraham T, Barold SS et al. Cardiac resynchronization therapy: part 1-issues before device implantation. J. Am. Coll. Cardiol. 46(12), 2153-2167 (2005).
14. Bax JJ, Bleeker GB, Marwick TH et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J. Am. Coll. Cardiol. 44(9), 1834-1840 (2004).
15. Suffoletto MS, Dohi K, Cannesson M, Saba S, Gorcsan J. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation 113(7), 960-968 (2006).
16. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am. J. Cardiol. 91(6), 684-688 (2003).
17. Achilli A, Sassara M, Ficili S et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS. J. Am. Coll. Cardiol. 42(12), 2117-2124 (2003).
18. Bleeker GB, Holman ER, Steendijk P et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J. Am. Coll. Cardiol. 48(11), 2243-2250 (2006).
19. Tops LF, Suffoletto MS, Bleeker GB et al. Speckle-tracking radial strain reveals left ventricular dyssynchrony in patients with permanent right ventricular pacing. J. Am. Coll. Cardiol. 50(12), 1180-1188 (2007).
20. Marsan NA, Henneman MM, Chen J et al. Real-time 3-dimensional echocardiography as a novel approach to quantify left ventricular dyssynchrony: a comparison study with phase analysis of gated myocardial perfusion single photon emission computed tomography. J. Am. Soc. Echocardiogr. 21(7), 801-807 (2008).
21. Ajmone MN, Henneman MM, Chen J et al. Left ventricular dyssynchrony assessed by two three-dimensional imaging modalities: phase analysis of gated myocardial perfusion SPECT and tri-plane tissue Doppler imaging. Eur. J. Nucl. Med. Mol. Imaging 35(1), 166-173 (2008).
22. Lardo AC, Abraham TP, Kass DA. Magnetic resonance imaging assessment of ventricular dyssynchrony: current and emerging concepts. J. Am. Coll. Cardiol. 46(12), 2223-2228 (2005).
23. Westenberg JJ, Lamb HJ, van der Geest RJ et al. Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy: head-to-head comparison between tissue doppler imaging and velocity-encoded magnetic resonance imaging. J. Am. Coll. Cardiol. 47(10), 2042-2048 (2006).
24. O'Connell JW, Schreck C, Moles M et al. A unique method by which to quantitate synchrony with equilibrium radionuclide angiography. J. Nucl. Cardiol. 12(4), 441-450 (2005).
25. Somsen GA, Verberne HJ, Burri H, Ratib O, Righetti A. Ventricular mechanical dyssynchrony and resynchronization therapy in heart failure: a new indication for Fourier analysis of gated blood-pool radionuclide ventriculography. Nucl. Med. Commun. 27(2), 105-112 (2006).
26. Botvinick EH, O'Connell JW, Kadkade PP et al. Potential added value of three-dimensional reconstruction and display of single photon emission computed tomographic gated blood pool images. J. Nucl. Cardiol. 5(3), 245-255 (1998).
27. Vilain D, Daou D, Casset-Senon D, Faraggi M, Le GD. Optimal 3-dimensional method for right and left ventricular fourier phase analysis in electrocardiography-gated blood-pool SPECT. J. Nucl. Cardiol. 8(3), 371-378 (2001).
28. Chen J, Garcia EV, Folks RD et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J. Nucl. Cardiol. 12(6), 687-695 (2005).
29. Garcia EV, Faber TL, Cooke CD, Folks RD, Chen J, Santana C. The increasing role of quantification in clinical nuclear cardiology: the Emory approach. J. Nucl. Cardiol. 14(4), 420-432 (2007).
30. Chen J, Henneman MM, Trimble MA et al. Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging. J. Nucl. Cardiol. 15(1), 127-136 (2008).
31. Yu CM, Abraham WT, Bax J et al. Predictors of response to cardiac resynchronization therapy (PROSPECT)-study design. Am. Heart J. 149(4), 600-605 (2005).
32. Chung ES, Leon AR, Tavazzi L et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 117(20), 2608-2616 (2008).
33. Trimble MA, Velazquez EJ, Adams GL et al. Repeatability and reproducibility of phase analysis of gated single-photon emission computed tomography myocardial perfusion imaging used to quantify cardiac dyssynchrony. Nucl. Med. Commun. 29(4), 374-381 (2008).
34. Trimble MA, Borges-Neto S, Velazquez EJ et al. Emerging role of myocardial perfusion imaging to evaluate patients for cardiac resynchronization therapy. Am. J. Cardiol. 102(2), 211-217 (2008).
35. Bonow RO, Bacharach SL, Crawford-Green C, Green MV. Influences of temporal smoothing on quantitation of left ventricular function by gated blood pool scintigraphy. Am. J. Cardiol. 64(14), 921-925 (1989).
36. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J. Comput. Assist. Tomogr. 3(3), 299-308 (1979).
37. Gait JR, Garcia EV, Robbins WL. Effects of myocardial wall thickness on SPECT quantification. IEEE Trans. Med. Imaging 9(2), 144-150 (1990).
38. Chen J, Faber TL, Cooke CD, Garcia EV. Temporal resolution of multiharmonic phase analysis of ECG-gated myocardial perfusion SPECT studies. J. Nucl. Cardiol. 15(3), 383-391 (2008).
39. Henneman MM, Chen J, Ypenburg C et al. Phase analysis of gated myocardial perfusion single-photon emission computed tomography compared with tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J. Am. Coll. Cardiol. 49(16), 1708-1714 (2007).
40. Henneman MM, Chen J, Dibbets-Schneider P et al. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J. Nucl. Med. 48(7), 1104-1111 (2007).
41. Bleeker GB, Kaandorp TA, Lamb HJ et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 113(7), 969-976 (2006).
42. Helm RH, Byrne M, Helm PA et al. Three-dimensional mapping of optimal left ventricular pacing site for cardiac resynchronization. Circulation 115(8), 953-961 (2007).
43. Bilchick KC, Dimaano V, Wu KC et al. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. J. Am. Coll. Cardiol. Imaging 1, 561-568 (2008).
44. Ypenburg C, van Bommel RJ, Delgado V et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cirdiac resynchronization therapy. J. Am. Coll. Cardiol. 52(17), 1402-1409 (2008).
45. Ypenburg C, Schalij MJ, Bleeker GB et al. Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients. J. Nucl. Med. 47(10), 1565-1570 (2006).
46. Ypenburg C, Schalij MJ, Bleeker GB et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur. Heart J. 28(1); 33-41 (2007).
47. Ypenburg C, Roes SD, Bleeker GB et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization. therapy. Am. J. Cardiol. 99(5), 657-660 (2007).
48. Adelstein EC, Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am. Heart J. 153(1), 105-112 (2007).
49. Van Campen CM, Visser FC, van der Weerdt AP et al.: FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy. Eur. J. Nucl. Med. Mol. Imaging 34(3), 307-308 (2007).
50. Braunschweig F, Sorenson J, von Bibra H et al. Effects of biventricular pacing on myocardial blood flow and oxygen consumption using carbon-11 acetate positron emission tomography in patients with heart failure. Am. J. Cardiol. 92(1), 95-99 (2003).
51. Nielsen JC, Boucher M, Jensen HK, Nielsen TT, Pedersen AK, Mortensen PT. Regional myocardial perfusion during chronic biventricular pacing and after acute change of the pacing mode in patients with congestive heart failure and bundle branch block treated with an atrioventricular sequential biventricular pacemaker. Eur. J. Heart Fail. 5(2), 179-186 (2003).
52. Sundell J, Engblom E, Koistinen J et al. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J. Am. Coll. Cardiol. 43(6), 1027-1033 (2004).
53. Nowak B, Stellbrink C, Sinha AM et al. Effects of cardiac resynchronization therapy on myocardial blood flow measured by oxygen-15 water positron emission tomography in idiopathic-dilated cardiomyopathy and left bundle branch block. Am. J. Cardiol. 93(4), 496-499 (2004).
54. Knaapen P, van Campen LM, de Cock CC et al. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 110(6), 646-651 (2004).
55. Lindner O, Vogt J, Kammeier A et al. Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy. Eur, Heart J. 26(1), 70-76 (2005).
56. Lindner O, Vogt J, Kammeier et al. Cardiac re-synchronization therapy: effects on myocardial perfusion at rest, after vasodilation and oxygen consumption. Nuklearmedizin 45(1), 10-14 (2006).
57. Neri G, Zanco P, Zanon F, Buchberger R. Effect of biventricular pacing on metabolism and perfusion in patients affected by dilated cardiomyopathy and left bundle branch block: evaluation by positron emission tomography. Europace 5(1), 111-115 (2003).
58. Nowak B, Sinha AM, Schaefer WM et al. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J. Am. Coll. Cardiol. 41(9), 1523-1528 (2003).
59. Ukkonen H, Beanlands RS, Burwash IG et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 107(1), 28-31 (2003).
60. Burri H, Sunthorn H, Somsen A et al. Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy. Europace 10(1), 374-378 (2008).
61. Nishioka SA, Martinelli Filho M, Brandão SC et al. Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy. J. Nucl. Cardiol. 14(6), 852-859 (2007).